Rock Health News


Research 4/6/20

Amidst a record $3.1B funding in Q1 2020, digital health braces for COVID-19 impact

Digital health venture funding had its strongest start ever in 2020, with a prodigious $3.1B invested across Q1. In February the COVID-19 pandemic hit the US, sending an immediate shock through public markets. The twin crises of a global pandemic and massive economic shifts will rapidly impact all market sectors, including digital health. To assess the scale, direction, and timing of the impact, we surveyed twelve leading healthcare investors between March 16 and March 20, 2020 (and included our own response in the sample). Although the responses paint a somber picture of the emerging funding environment, there is a tangible sense of resolve to not waste this crisis—to leverage digital health solutions to immediately combat the pandemic and build on that momentum to radically reshape the way healthcare is delivered in the US and globally.

How Rock Health portfolio companies are responding to COVID-19

Digital solutions are enabling communication, surveillance, diagnostics, treatment, and expanded capacity when healthcare needs it most. Our portfolio companies have jumped into action—here’s a look at just a few of the ways they’re supporting patients, providers, and researchers during the COVID-19 pandemic.

Funding 1/7/20

In 2019, digital health celebrated six IPOs as venture investment edged off record highs

Across the last decade, digital health has grown from a blip on the radar of investors to a robust sector receiving nearly one in ten venture dollars invested in the United States. In 2019, 359 US digital health startups raised $7.4B from 627 investors. Though six digital health companies entered the public markets in 2019, exits were a somewhat mixed bag, with M&A below trend at 112 deals across 2019.

The state of gender equity at healthcare startups and VCs in 2019

Despite significant disparities in healthcare leadership today, industry leaders and employees share a belief that gender parity can be achieved within our lifetime. This year, we surveyed individuals working at healthcare startups and VCs to understand how they perceive initiatives at their organizations to promote the advancement of women, and offer concrete solutions for leaders to actively advance gender equity.

Digital Health Consumer Adoption Report 2019

Rock Health and the Stanford Center for Digital Health release their findings from the 2019 Consumer Adoption Survey. In 2019, overall consumer adoption of digital health leveled off near the 2018 high water mark. The five-year picture represented in our annual survey is one of a steady transition to a progressively more digital consumer healthcare experience.

From concept to conception: Our investment in Natalist

When Halle Tecco set out to build Rock Health nearly ten years ago, she saw a need to support entrepreneurs using technology to make healthcare massively better. Today, we’re thrilled to announce our investment in her latest venture, Natalist, a company conceived to close the glaring gaps she encountered on her path to parenthood—and fueled by the belief that those who want to have children deserve a better way. We’re humbled to be a part of Natalist’s $5M seed round and to back an incredible team on a mission to radically improve the fertility experience.

Funding 10/1/19

Q3 2019: Digital health funding moderates after particularly strong first half

Though funding slowed from the $2B per quarter pace in the first half of the year, digital health companies raised $1.3B in venture capital in Q3 2019 for a total of $5.5B in the year to date. This puts the sector on track for the second largest funding year ever. As in 2018, large deals continue to drive the overall trend. In this market update we discuss public market performance of the five 2019 digital health IPOs (early results are mixed) and two hot areas of investment: behavioral health and women’s health.

Medications managed: Our investment in Arine

Medication errors cost the US healthcare system over $525B each year—roughly one in every six healthcare dollars spent. We’re excited to announce our investment in Arine, whose solution combines data science with clinical expertise to ensure patients are on the safest and most effective medication regimens.

Making any medicine precision medicine: Welcome, InsightRX!

We’re proud to announce our participation in InsightRX’s $10M Series A funding round to support their mission of individualizing drug treatment at the point of care.

Innovation and collaboration in the new age of consumer healthcare: A Q&A with GSK

As consumers increasingly take control of their own health and wellness, they drive market demand more directly. Devices, apps, and services are being created and tailored to meet their needs, enabling consumers to actively engage in health and wellness decision-making. To dig a little deeper beneath the surface of how industry players are adapting to this shift, we caught up with experts on the inside at GSK Consumer Healthcare, a Rock Health partner.

Better health, gut first: Our investment in Vivante Health

We’re proud to announce our newest investment in Vivante Health, the first all-in-one digital solution for digestive health and complex inflammatory conditions. Welcome, Vivante!

Funding 7/1/19

2019 Midyear Digital Health Market Update: Exits are heating up

$4.2B was invested in digital health through the first half of 2019. The sector continues to experience healthy growth—we still don’t see the telltale signs of an investment bubble. Here we take stock of the capital invested in digital health startups since 2011—$29.4B of which is waiting on liquidity. We examine two avenues to return this capital: public offerings and acquisition by large non-healthcare companies.

Imagining a world free of diabetic foot ulcers: Our investment in Podimetrics

Since 2012, Podimetrics has worked tirelessly on a remote patient monitoring (RPM) solution to tackle the devastating problem of diabetic foot ulcers. With clinically validated sensor technology and care coordination, Podimetrics is now launching its product to additional commercial payers and at-risk providers. We’re thrilled to announce our participation in Podimetrics’ $13.4M Series B.

Research 4/8/19

Building Pharma-Digital Therapeutic Alliances

Digital therapeutic and pharmaceutical companies are partnering to build, validate, and expand access to new, software-based solutions that improve patient outcomes. This is new territory with few precedents, and the strategies for building successful alliances remain uncertain. Drawing from numerous interviews with digital therapeutic, pharma, and health plan leaders, this research outlines how to overcome execution risks and build successful pharma-digital therapeutic alliances.

Other 12/17/18

How an eighty-year-old health plan is building the healthcare model of the future by working with Rock Health

Since 2015, Blue Shield of California has partnered with Rock Health to gain exposure to digital health and elevate its position as an innovative healthcare company. Through its partnership with Rock Health, Blue Shield of California has showcased thought leadership, collaborated on research, and gained unparalleled insight into the frontlines of healthcare innovation.

Featured 3/1/18

The real-world effects of digital health: Announcing the Impact Project

After seven years, we’ve seen $23B invested into thousands of digital health companies. But we wanted to know: what has been the real-world impact of digital health? We were moved to learn just how many lives had been significantly changed by a new wave of technology. We aim to shift the digital health dialogue from one focused on the degree of investment and future expectations to one about digital health’s effect on patients and healthcare outcomes. In that spirit, this ongoing project brings you stories of people living far outside Silicon Valley and the companies shifting the healthcare status quo who have made an impact on their lives.

Featured 2/20/18

Demystifying AI and Machine Learning in Healthcare

AI in healthcare feels inevitable: Optimists predict that artificial intelligence and machine learning (AI/ML) will diagnose disease better and earlier, treat illness more precisely, and engage patients more efficiently than today’s healthcare system does. On top of this, AI/ML is expected to streamline business operations and restore sanity (and humanity) to the clinician experience. To separate hype from reality, read our 50-page white paper, Demystifying AI and Machine Learning in Healthcare.